SomnoMed North America specializes in innovative solutions for the treatment of obstructive sleep apnea (OSA) through its advanced oral appliance technologies. The company focuses on developing custom-fitted devices that are designed to improve patient comfort and compliance while effectively managing OSA symptoms. Their flagship product, the SomnoDent, utilizes a unique design that allows for adjustable jaw positioning, which helps to maintain an open airway during sleep. This approach not only enhances the effectiveness of the treatment but also prioritizes patient comfort, making it a preferred choice for many individuals suffering from sleep apnea.

In addition to their core products, SomnoMed emphasizes the importance of scientific research and clinical validation in their technology development. The company collaborates with dental and medical professionals to ensure that their devices are backed by robust clinical evidence, demonstrating their efficacy and safety. SomnoMed's commitment to continuous innovation is evident in their ongoing pipeline of products, which aims to address various aspects of sleep-related disorders and improve overall patient outcomes. Through these efforts, SomnoMed North America positions itself as a leader in the field of sleep medicine, dedicated to enhancing the quality of life for those affected by sleep apnea.

United States

SomnoMed® leads the world in the development of medical devices for the treatment of mild-to-moderate Obstructive Sleep Apnea, and has innovated OSA treatment options since 2004. Each custom-made oral appliance is designed with patient comfort and therapy effectiveness as the priority, and we strive with the dental and healthcare communities to support 100% therapy compliance in OSA treatment.  Learn more at https://somnomed.com/en/ or call 888-447-6673.

SomnoMed North America

Company Details